![35-year-old American moved to Chengdu and lives on $30,000 a year: ‘[It’s] poverty in America, but in China I’m living large’](https://image.cnbcfm.com/api/v1/image/108167583-1751548516689-chinacelia1.jpg?v=1751549197&w=1920&h=1080 "35-year-old American moved to Chengdu and lives on $30,000 a year: ‘[It’s] poverty in America, but in China I’m living large’")
Bristol-Myers Squibb Co
Stocks making the most important moves midday: Microsoft, Chegg, Zoom Video clip, Paramount and extra
Check out out the firms building headlines in midday trading. Zoom Video clip Communications — The software stock included virtually 2% forward of its third-quarter earnings thanks right after industry shut. Analysts polled by FactSet expect $1.08 for every share in earnings and profits of $1.12 billion for the quarterly period, as opposed to the […]
Read More
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter, down […]
Read More
These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass
One of the downsides of taking new anti-obesity medications is that patients tend to lose lean muscle mass along with body fat. What this means for patients over the long term isn’t fully known, but there are several pharmaceutical companies studying the side effect and hoping to develop therapies that might regulate the condition. In […]
Read More
Evercore ISI says this biotech stock is a high risk, high reward play, with more than 200% upside
Evercore ISI initiated coverage of Aclaris Therapeutics , a clinical stage biotech working on immunology and inflammation drugs, at an outperform, saying the market is underpricing its odds for success heading into the release of clinical trial data. “We think the stock could trade up 300%+ on positive data (with more upside after the short-term […]
Read More
Drugmakers opt in to Medicare drug price negotiations – here’s what happens next
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, even after many of them sued to halt the […]
Read More
Federal judge declines to block Medicare drug price negotiations
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on Friday declined to block the Biden administration from implementing Medicare drug price negotiations, upholding for now a controversial process that aims to make costly medications […]
Read More
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
In this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images AstraZeneca and Boehringer Ingelheim on Wednesday told CNBC they will agree to participate in the first round of Medicare drug price negotiations, even after both pharmaceutical companies […]
Read More
Judge withdraws from Medicare drug price case after stock ownership is revealed
Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District Court Southern District of Ohio after taking his oath of office, Monday, Jan. 14, 2019, in Cedarville, Ohio. John Minchillo | AP A federal judge on Friday withdrew from a case that could block Medicare from negotiating over drug prices, […]
Read More
Medicare wants to cut the price on an Eli Lilly drug. What it means for LLY shares
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
In this photo illustration, Eliquis is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images Medicare is set to negotiate prices for 10 different drugs with manufacturers in a bid to make those costly treatments more affordable for older Americans – a […]
Read More